Thermo Fisher Scientific · Multi-Quarter Financial Trends

14 quarters · As reported by the company · Amounts in USD billions← TMO

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-27	11.99	+10.5%	—	2.09	1.74	14.5%	1.68	4.68	1.00	0.18
FY2026 Q1	2026-03-28	11.01	+6.2%	—	1.86	1.65	15.0%	0.82	4.43	3.00	0.16
FY2025 Q4	2025-12-31	12.22	+7.2%	—	2.26	1.98	16.2%	2.99	5.21	0.04	0.16
FY2025 Q3	2025-09-27	11.12	+4.9%	—	1.94	1.62	14.5%	1.84	4.27	0.96	0.16
FY2025 Q2	2025-06-28	10.86	+3.0%	—	1.83	1.62	14.9%	1.11	4.28	0.00	0.16
FY2025 Q1	2025-03-29	10.36	+0.2%	—	1.72	1.51	14.5%	0.36	3.98	2.00	0.15
FY2024 Q4	2024-12-31	11.40	+4.7%	—	2.02	3.16	27.7%	2.81	4.78	1.00	0.15
FY2024 Q3	2024-09-28	10.60	−0.8%	—	1.84	1.63	15.4%	1.89	4.25	0.00	0.15
FY2024 Q2	2024-06-29	10.54	−1.6%	—	1.82	1.55	14.7%	1.66	4.04	0.00	0.15
FY2024 Q1	2024-03-30	10.35	—	—	1.66	—	—	0.90	3.46	3.00	0.14
FY2023 Q4	2023-12-31	10.89	+2.0%	—	1.85	5.96	54.7%	3.32	4.20	0.00	0.14
FY2023 Q3	2023-07-01	10.69	—	—	1.58	—	—	1.26	3.51	0.00	0.14
FY2023 Q2	2023-04-01	10.71	—	—	1.56	—	—	0.27	3.32	3.00	0.12
FY2022 Q4	2022-10-01	10.68	—	—	1.71	—	—	1.39	3.79	0.00	0.12

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.